TREATMENT
An automated external defibrillator in the home did not reduce all-cause mortality in patients at risk of cardiac arrest
| The first 150 words of the full text of this article appear below. |
G H Bardy
Dr G H Bardy, Seattle Institute for Cardiac Research, Seattle, WA, USA; gbardy@sicr.org
In stable patients at increased risk of sudden cardiac arrest, does having an automated external defibrillator (AED) in the home reduce all-cause mortality compared with training in usual emergency procedures?
Design: randomised controlled trial (Home Automated External Defibrillator Trial [HAT]).
Allocation: {concealed}.*
Blinding: blinded (outcome adjudication committee).
Follow-up period: median 37 months.
Setting: 178 clinical sites in the USA, Canada, Australia, the UK, New Zealand, the Netherlands, and Germany.
Patients: 7001 patients (median age 62 y, 83% men) who had had anterior-wall myocardial infarction, were not candidates for implantable cardioverter-defibrillator (ICD) therapy, and had a spouse or companion at home who was willing and able to perform the study interventions.
Intervention:
provision of an AED for home use (n = 3495) or no AED (n = 3506). In case of suspected sudden cardiac arrest,
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
